Market Cap 35.27M
Revenue (ttm) 2.19M
Net Income (ttm) -24.19M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -1,104.57%
Debt to Equity Ratio 0.00
Volume 106,300
Avg Vol 240,482
Day's Range N/A - N/A
Shares Out 6.19M
Stochastic %K 57%
Beta 2.28
Analysts Strong Sell
Price Target $56.28

Company Profile

Aligos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapeutics to address unmet medical needs in liver and viral diseases. Its drug candidate, ALG-055009, a small molecule THR-ß agonist that is in the Phase 2a clinical trial for the treatment of metabolic dysfunction-associated steatohepatitis and obesity. The company also develops pevifoscorvir sodium, a capsid assembly modulator, which is in Phase 2 B clinical trial; and ALG-097558, a sm...

Industry: Biotechnology
Sector: Healthcare
Phone: 800 466 6059
Address:
One Corporate Drive, 2nd Floor, South San Francisco, United States
ALGSmoon
ALGSmoon May. 29 at 2:45 AM
$ALGS this is very sus. It’s going up with red candles everywhere and the order flow is very negative. Really feels like a someone is building a short position in advance of something happening.
0 · Reply
ALGSmoon
ALGSmoon May. 27 at 9:38 PM
$ALGS they may not even pump it before the offering. They may just drop it on us here.
0 · Reply
ALGSmoon
ALGSmoon May. 27 at 6:12 PM
$ALGS checking in here. Seems to be doing ALGS things.
0 · Reply
HedgeUrHedge
HedgeUrHedge May. 17 at 2:00 PM
$ALGS unfortunately we have a lot of short bots and paid for actors/entities who try to manipulate sentiment when in reality they are wrong and know absolutely nothing about this company and the impact of their drug but why not short it anyway and throw rationale out the window lol. Price taget is now $800/share for me. Adding more on Monday.
1 · Reply
ALGSmoon
ALGSmoon May. 15 at 8:09 PM
$ALGS unfortunately, this is going to retest all time lows.
0 · Reply
Daphael
Daphael May. 15 at 2:37 PM
$ALGS amoytop shareholders meeting was supposed to be within 30days. I don't think they would hold onto positive news for an extra 15 days.
0 · Reply
ALGSmoon
ALGSmoon May. 15 at 2:07 PM
$ALGS looks like some smart money has thrown in the towel.
0 · Reply
STACKD0E
STACKD0E May. 13 at 3:44 PM
0 · Reply
ALGSmoon
ALGSmoon May. 13 at 1:29 PM
$ALGS today will be bad. Shorts locked and loaded.
0 · Reply
Zezed1
Zezed1 May. 13 at 11:27 AM
$ALGS I’m going to wait forever for this to go back to my avg of 25 😅
0 · Reply
Latest News on ALGS
Aligos Therapeutics initiated with a Buy at Lake Street

2026-05-28T13:28:16.000Z - 3 days ago

Aligos Therapeutics initiated with a Buy at Lake Street


Aligos Therapeutics presents data at EASL congress

2026-05-27T09:15:09.000Z - 4 days ago

Aligos Therapeutics presents data at EASL congress


Aligos Therapeutics Earnings release: Q1 2026

May 7, 2026, 4:00 PM EDT - 24 days ago

Aligos Therapeutics Earnings release: Q1 2026


Aligos Therapeutics Quarterly report: Q1 2026

May 7, 2026, 4:00 PM EDT - 24 days ago

Aligos Therapeutics Quarterly report: Q1 2026


Aligos Therapeutics Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 4 weeks ago

Aligos Therapeutics Proxy statement: Proxy filing


Aligos Therapeutics Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 4 weeks ago

Aligos Therapeutics Proxy statement: Proxy filing


Aligos Therapeutics Slides: Corporate presentation

Apr 14, 2026, 7:00 AM EDT - 6 weeks ago

Aligos Therapeutics Slides: Corporate presentation


Aligos Therapeutics initiated with a Buy at WestPark Capital

2026-03-26T13:00:14.000Z - 2 months ago

Aligos Therapeutics initiated with a Buy at WestPark Capital


Aligos Therapeutics Slides: Corporate presentation

Mar 19, 2026, 7:00 AM EDT - 2 months ago

Aligos Therapeutics Slides: Corporate presentation


Aligos Therapeutics assumed with a Buy at Jefferies

2026-03-19T09:15:20.000Z - 2 months ago

Aligos Therapeutics assumed with a Buy at Jefferies


Aligos Therapeutics Annual report: Q4 2025

Mar 5, 2026, 9:30 AM EST - 3 months ago

Aligos Therapeutics Annual report: Q4 2025


Aligos Therapeutics Earnings release: Q4 2025

Mar 5, 2026, 9:30 AM EST - 3 months ago

Aligos Therapeutics Earnings release: Q4 2025


Aligos Therapeutics reports Q4 EPS ($1.91), consensus ($2.49)

2026-03-05T13:14:38.000Z - 3 months ago

Aligos Therapeutics reports Q4 EPS ($1.91), consensus ($2.49)


Aligos Therapeutics appoints James Hassard as EVP, CCO

2026-01-13T13:16:17.000Z - 4 months ago

Aligos Therapeutics appoints James Hassard as EVP, CCO


Aligos Therapeutics initiated with a Buy at UBS

2026-01-07T13:21:19.000Z - 5 months ago

Aligos Therapeutics initiated with a Buy at UBS

APGE COGT IDYA IVA KOD SABS VTYX


Aligos Therapeutics Presents Positive Data at HEP-DART 2025

Dec 11, 2025, 8:00 AM EST - 6 months ago

Aligos Therapeutics Presents Positive Data at HEP-DART 2025


Aligos Therapeutics Quarterly report: Q3 2025

Nov 6, 2025, 7:00 AM EST - 7 months ago

Aligos Therapeutics Quarterly report: Q3 2025


Aligos Therapeutics Earnings release: Q3 2025

Nov 6, 2025, 7:00 AM EST - 7 months ago

Aligos Therapeutics Earnings release: Q3 2025


Aligos Therapeutics to Present at Upcoming Investor Conferences

Nov 4, 2025, 8:30 AM EST - 7 months ago

Aligos Therapeutics to Present at Upcoming Investor Conferences


Aligos Therapeutics Quarterly report: Q2 2025

Aug 6, 2025, 4:00 PM EDT - 10 months ago

Aligos Therapeutics Quarterly report: Q2 2025


Aligos Therapeutics Earnings release: Q2 2025

Aug 6, 2025, 4:00 PM EDT - 10 months ago

Aligos Therapeutics Earnings release: Q2 2025


Aligos Therapeutics Quarterly report: Q1 2025

May 6, 2025, 9:30 AM EDT - 1 year ago

Aligos Therapeutics Quarterly report: Q1 2025


Aligos Therapeutics Earnings release: Q1 2025

May 6, 2025, 9:30 AM EDT - 1 year ago

Aligos Therapeutics Earnings release: Q1 2025


Aligos Therapeutics Proxy statement: Proxy Filing

Apr 28, 2025, 8:00 AM EDT - 1 year ago

Aligos Therapeutics Proxy statement: Proxy Filing


Aligos Therapeutics Proxy statement: Proxy Filing

Apr 28, 2025, 8:00 AM EDT - 1 year ago

Aligos Therapeutics Proxy statement: Proxy Filing


Aligos Therapeutics Proxy statement: Proxy Filing

Apr 16, 2025, 8:00 AM EDT - 1 year ago

Aligos Therapeutics Proxy statement: Proxy Filing


Aligos Therapeutics Presents Positive Data at APASL 2025

Mar 26, 2025, 8:00 AM EDT - 1 year ago

Aligos Therapeutics Presents Positive Data at APASL 2025


Aligos Therapeutics Annual report: Q4 2024

Mar 10, 2025, 9:30 AM EDT - 1 year ago

Aligos Therapeutics Annual report: Q4 2024


Aligos Therapeutics Earnings release: Q4 2024

Mar 10, 2025, 9:30 AM EDT - 1 year ago

Aligos Therapeutics Earnings release: Q4 2024


Aligos Therapeutics Quarterly report: Q3 2024

Nov 6, 2024, 4:00 PM EST - 1 year ago

Aligos Therapeutics Quarterly report: Q3 2024


Aligos Therapeutics Earnings release: Q3 2024

Nov 6, 2024, 4:00 PM EST - 1 year ago

Aligos Therapeutics Earnings release: Q3 2024


Aligos Therapeutics Transcript: Study Result

Sep 19, 2024, 8:30 AM EDT - 1 year ago

Aligos Therapeutics Transcript: Study Result


Aligos Therapeutics Press release: Study Result

Sep 19, 2024, 8:30 AM EDT - 1 year ago

Aligos Therapeutics Press release: Study Result


Aligos Therapeutics Slides: Study Result

Sep 19, 2024, 8:30 AM EDT - 1 year ago

Aligos Therapeutics Slides: Study Result


Aligos Therapeutics Announces Reverse Stock Split

Aug 15, 2024, 9:00 AM EDT - 1 year ago

Aligos Therapeutics Announces Reverse Stock Split


Aligos Therapeutics Quarterly report: Q2 2024

Aug 6, 2024, 4:00 PM EDT - 1 year ago

Aligos Therapeutics Quarterly report: Q2 2024


Aligos Therapeutics Earnings release: Q2 2024

Aug 6, 2024, 4:00 PM EDT - 1 year ago

Aligos Therapeutics Earnings release: Q2 2024


Aligos Therapeutics Quarterly report: Q1 2024

May 7, 2024, 4:00 PM EDT - 2 years ago

Aligos Therapeutics Quarterly report: Q1 2024


Aligos Therapeutics Earnings release: Q1 2024

May 7, 2024, 4:00 PM EDT - 2 years ago

Aligos Therapeutics Earnings release: Q1 2024


ALGSmoon
ALGSmoon May. 29 at 2:45 AM
$ALGS this is very sus. It’s going up with red candles everywhere and the order flow is very negative. Really feels like a someone is building a short position in advance of something happening.
0 · Reply
ALGSmoon
ALGSmoon May. 27 at 9:38 PM
$ALGS they may not even pump it before the offering. They may just drop it on us here.
0 · Reply
ALGSmoon
ALGSmoon May. 27 at 6:12 PM
$ALGS checking in here. Seems to be doing ALGS things.
0 · Reply
HedgeUrHedge
HedgeUrHedge May. 17 at 2:00 PM
$ALGS unfortunately we have a lot of short bots and paid for actors/entities who try to manipulate sentiment when in reality they are wrong and know absolutely nothing about this company and the impact of their drug but why not short it anyway and throw rationale out the window lol. Price taget is now $800/share for me. Adding more on Monday.
1 · Reply
ALGSmoon
ALGSmoon May. 15 at 8:09 PM
$ALGS unfortunately, this is going to retest all time lows.
0 · Reply
Daphael
Daphael May. 15 at 2:37 PM
$ALGS amoytop shareholders meeting was supposed to be within 30days. I don't think they would hold onto positive news for an extra 15 days.
0 · Reply
ALGSmoon
ALGSmoon May. 15 at 2:07 PM
$ALGS looks like some smart money has thrown in the towel.
0 · Reply
STACKD0E
STACKD0E May. 13 at 3:44 PM
0 · Reply
ALGSmoon
ALGSmoon May. 13 at 1:29 PM
$ALGS today will be bad. Shorts locked and loaded.
0 · Reply
Zezed1
Zezed1 May. 13 at 11:27 AM
$ALGS I’m going to wait forever for this to go back to my avg of 25 😅
0 · Reply
ALGSmoon
ALGSmoon May. 12 at 1:47 PM
$ALGS new range. $5.80- 6.80. Unclear what pushes it higher, very clear what pushes it lower.
0 · Reply
Daphael
Daphael May. 12 at 11:07 AM
$ALGS amoytop shareholders meeting was supposed to be within 30days, if no information in the next 3 days this is going to tank hard, without the deal going through there will be an offering
1 · Reply
ALGSmoon
ALGSmoon May. 12 at 2:46 AM
$ALGS are we just waiting for the offering to take us sub $1?
0 · Reply
Suppandi
Suppandi May. 12 at 1:08 AM
$ALGS Please go to $100
0 · Reply
ALGSmoon
ALGSmoon May. 8 at 3:23 PM
$ALGS shorts appear to attack any pop and it seems to work far more often than not.
0 · Reply
forprofit12
forprofit12 May. 8 at 3:22 PM
$ALGS same price action everyday. Green pre-market and then red by EOD
0 · Reply
Daphael
Daphael May. 8 at 1:39 PM
$ALGS only people selling at this price are shorts or people exiting with a lose, who else would sell
1 · Reply
STACKD0E
STACKD0E May. 8 at 1:27 PM
0 · Reply
SpikeUp7119
SpikeUp7119 May. 8 at 12:03 PM
0 · Reply
aletz
aletz May. 8 at 3:45 AM
$ALGS Amoytop shareholders voted in favour for in-licensing pevy and milestone terms.
1 · Reply
IPOARMY1
IPOARMY1 May. 8 at 12:18 AM
$ALGS . The recommendation from the DSMB to increase participants has the potential to increase the probability of success of the B-SUPREME study. " It is important to note, that prior to the B-SUPREME study there has not been a randomized controlled study of treatment naïve chronic HBV infection participants using tenofovir disoproxil fumarate (TDF) as the active comparator to measure HBV DNA response with the most sensitive PCR assay currently available (LLOQ <10 IU/mL). " 🤔🤔🤔
0 · Reply
Daphael
Daphael May. 7 at 8:27 PM
$ALGS that release was telling us what was already known, so the price will probably stay around $6.00 maybe $6.40 for the next few months
0 · Reply